Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases... Show more
a developer of mechanism-targeted drugs to treat human cancers
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IRLAX | 71.89 | N/A | N/A |
Voya Russell Large Cap Growth Idx Port A | |||
FERCX | 38.14 | N/A | N/A |
Fidelity Advisor Emerging Asia C | |||
DEMZX | 19.72 | N/A | N/A |
Macquarie Emerging Markets R6 | |||
FWOZX | 15.31 | N/A | N/A |
Fidelity Advisor Women's Leadership Z | |||
EAMAX | 15.16 | N/A | N/A |
Lord Abbett Emerging Markets Equity A |
A.I.dvisor tells us that CYCCP and SRPT have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCCP and SRPT's prices will move in lockstep.
Ticker / NAME | Correlation To CYCCP | 1D Price Change % | ||
---|---|---|---|---|
CYCCP | 100% | +1.55% | ||
SRPT - CYCCP | 23% Poorly correlated | -9.60% | ||
AURA - CYCCP | 21% Poorly correlated | -7.28% | ||
KZIA - CYCCP | 21% Poorly correlated | +5.13% | ||
QSI - CYCCP | 21% Poorly correlated | -4.88% | ||
ALNY - CYCCP | 21% Poorly correlated | -6.98% | ||
More |